HIT Consultant highlighted the Lumea and Verily strategic partnership on their website.
What You Should Know:
– Verily and Lumea announced a strategic partnership today to develop products. These products will diagnose, prognose, and guide prostate cancer therapy selection with improved objectivity and efficiency.
– Lumea’s integrated digital pathology solution will validate Verily’s AI method for improving cancer detection and grading in partnership with Google Health.
Read the full article here.
About HIT Consultant
Founded in 2012, HIT Consultant is the leading source of healthcare technology news, analysis, and insights for healthcare executives, physicians, and providers. Our content provides editorial insights on health IT, EHRs, population health management, digital health, telehealth, accountable care, patient engagement, and startups. With over 100k unique visits monthly, it is the leading destination for forward-thinking healthcare business leaders and influencers.
